caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1558302448

Ryan Kauffman

PRACTICEHICKORY MEDICAL DIRECT PRIMARY CARE, LLCSee all providers at this practice →
Family PracticeBellefontaine, OHI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
REFERRAL NETWORK

Where Ryan Kauffman's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 13 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Pathology Laboratories, Inc.
Clinical Laboratory · Toledo, OH
141671
Hassan Semaan
Diagnostic Radiology · Napoleon, OH
103554
COUNTY OF LOGAN OFFICE OF AUDITOR84489
Gregg Fulmer
Hospitalist · Bellefontaine, OH
47576
NPI 111495423741121
Charles Kratz
Family Practice · West Liberty, OH
39104
Darlene Weyer
Diagnostic Radiology · Lima, OH
2336
Muhammad Azrak
Internal Medicine · Bellefontaine, OH
1843
NPI 12856170681632
Michael Donnally
Cardiology · Marysville, OH
1548
June Hinkle
Nurse Practitioner · Bellefontaine, OH
1546
LIMA MEMORIAL JOINT OPERATING COMPANY1336
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
60
Beneficiaries
—
Total drug cost
$8K
Distinct drugs
5
Brand share
20.0%
Top prescribed drugs
Doxazosin Mesylate12 claims
Lisinopril12 claims
Lovastatin12 claims
Metoprolol Succinate12 claims
Rivaroxaban12 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.